Active · per the CBE, 17 September 2026
DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE logo

DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE

BE0439896582

Rechtspersoon Private limited company 1 establishment

DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE is a healthcare practice in Pajottegem. Private Limited, started on 29 December 1989, 1 establishment.

Dorpsstraat 58, 1755 Pajottegem dokterpierreagneessens.be

Behind the company: Pierre Agneessens, Veronique Driegelinck.

Active for

36 year, 8 months

Financials

Financial year 2025

DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE from Pajottegem, company number BE0439896582, closed financial year 2025 with a result of € 84,524 after tax. For that financial year DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE recorded a gross margin of € 159,279 and equity of € 587,355. Compared with financial year 2024, the result moved from € 70,463 to € 84,524. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on May 27, 2026.

What it is worth Growing

€ 587,355

▲ 3% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 84,524

▲ 20% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 41,624

▼ 27% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 65,229 paid out

77 % of the profit went to the shareholders, the rest stayed in the company.

People and assets in 2025

Vehicles and equipment

€ 3,258

▼ 79% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 112

▼ 65% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 26,535

▼ 10% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
2022202320242025Change 2024 → 2025
Gross margin € 112,822 € 74,495 € 155,214 € 159,279 ▲ 3%
Profit after taxes € 46,232 € 17,475 € 70,463 € 84,524 ▲ 20%
Equity € 514,812 € 511,095 € 568,060 € 587,355 ▲ 3%
Total debts € 190,949 € 28,534 € 52,569 € 46,397 ▼ 12%
Cash € 191,843 € 75,995 € 56,678 € 41,624 ▼ 27%
Land & buildings € 434,472 € 413,588 € 396,053 € 373,457 ▼ 6%
Retained profit € 419,474 € 415,757 € 472,722 € 492,017 ▲ 4%
Dividend € 0 € 21,191 € 13,498 € 65,229 ▲ € 51,731
Balance sheet total € 705,760 € 539,629 € 620,629 € 633,752 ▲ 2%

Key figures of DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE?

What happened at DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

  • New annual accounts for financial year 2025: profit of € 84,524 (▲ 20% vs 2024). Source: NBB ↗
  • Veronique Driegelinck became a director. NBB
  • Pierre Agneessens became a director. NBB
  • New establishment in Pajottegem. KBO
  • Start of the company according to the CBE. KBO

In short

From € 46,232 profit in 2022 to € 84,524 profit in 2025.

Paid € 94,398 in corporate taxes since 2022.

Best year ever: 2025, with € 84,524 profit.

Paid out € 99,918 in dividends to the owners in total.

Management

Pierre Agneessens Veronique Driegelinck
DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE

Behind DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE are Pierre Agneessens and Veronique Driegelinck.

See the full network in the app

Directors

According to the 2025 annual accounts

Pierre Agneessens

Director

since 2023

Veronique Driegelinck

Director

since 2023

Establishments

Establishment units

Physical locations of this company

Registered office

Dorpsstraat 58

1755 Pajottegem

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

Technologies

Amazon CloudFrontGoogle FontsGoogle Tag Manager

Certifications & Partners

FEB/VBO

Hosting & Email

Email provider

Self-hosted

Hosting

AMAZON-02 - Amazon.com, Inc., US

Website info

HTTPS Ja
Indexable pages 5
Languages NL

Features

Webshop Ads Contact page

Security

HTTPS
SPF
DMARC

Network

Load balancing

Details

Company number
0439.896.582
VAT number
BE 0439.896.582
Registered office
Dorpsstraat 58, 1755 Pajottegem
Names & denominations
DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE
Enterprise type
Rechtspersoon
Legal form
Private limited company
Legal situation
Normale toestand
Start date
29 December 1989
Peppol
Active · Active since 27 Nov 2024
Activities · NACE

Activiteiten van medische beeldvorming en medische laboratoria

Activiteiten van medische laboratoria

Frequently asked questions

What does DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE do?
DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE is a healthcare practice in Pajottegem. Private Limited, started on 29 December 1989, 1 establishment.
What is the address of DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE?
The registered office of DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE is located at Dorpsstraat 58, 1755 Pajottegem.
Is DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE still active?
Yes. According to the CBE (17 September 2026) DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE is active, legal situation “Normale toestand”, started on 29 December 1989.
Is DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE registered on Peppol?
Yes, DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE is registered on the Peppol network with ID 0208:0439896582.
What is the enterprise number of DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE?
The enterprise number of DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE is BE0439896582.
When was DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE founded?
DR PIERRE AGNEESSENS, ALGEMENE GENEESKUNDE was founded on 29 December 1989.